e-learning
resources
Vienna 2009
Monday, 14.09.2009
Exacerbations of COPD and bronchiectasis: aetiology and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhalation antibacterial therapy of COPD acute exacerbation
M. Nefedova, L. Sokolova, E. Shmelev (Moscow, Russian Federation)
Source:
Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session:
Exacerbations of COPD and bronchiectasis: aetiology and treatment
Session type:
Thematic Poster Session
Number:
2344
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Nefedova, L. Sokolova, E. Shmelev (Moscow, Russian Federation). Inhalation antibacterial therapy of COPD acute exacerbation. Eur Respir J 2009; 34: Suppl. 53, 2344
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
An analysis of non-effective empiric antibacterial therapy in COPD acute exacerbation
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
Combined nebulization therapy in acute asthma exacerbation
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001
Antibiotics in acute exacerbation of asthma and COPD
Source: Eur Respir Monogr 2017; 75: 150-158
Year: 2017
Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 283s
Year: 2003
Efficacy and safety of various antimicrobial regimens in the treatment of acute exacerbations of chronic bronchitis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
Efficacy of inhaled heparin is effective in the treatment of acute exacerbation of asthma
Source: Annual Congress 2007 - New drugs for asthma
Year: 2007
N-acetylcysteine for the treatment of acute exacerbations of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 374s
Year: 2002
Microorganisms resistant to conventional antimicrobial treatment in acute exacerbation of COPD
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
The role of nebulised budesonide in the treatment of acute exacerbations of COPD
Source: Eur Respir J 2007; 30: 399-400
Year: 2007
Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 343s
Year: 2004
Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2001; 18: Suppl. 33, 146s
Year: 2001
The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Speed of recovery after antibiotic treatment of acute exacerbations of moderate to severe COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
Duration of systemic corticosteroids treatment in COPD exacerbations
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
Association of COPD inhaled medication adherence with hospitalization for acute exacerbation of COPD (AECOPD)
Source: International Congress 2017 – COPD management
Year: 2017
Inhaled corticosteroids and hospitalisation due to exacerbation of COPD
Source: Eur Respir J 2003; 22: 286-289
Year: 2003
Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013
Pharmacologic treatment of exacerbations of COPD
Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept